APA

Fernandez C. A., Stewart E., Panetta J. C., Wilkinson M. R., Morrison A. R., Finkelman F. D., Sandlund J. T., Pui C. H., Jeha S., Relling M. V. & Campbell P. K. (20140918). Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase. : Cancer chemotherapy and pharmacology.

Chicago

Fernandez C A, Stewart E, Panetta J C, Wilkinson M R, Morrison A R, Finkelman F D, Sandlund J T, Pui C H, Jeha S, Relling M V and Campbell P K. 20140918. Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase. : Cancer chemotherapy and pharmacology.

Harvard

Fernandez C. A., Stewart E., Panetta J. C., Wilkinson M. R., Morrison A. R., Finkelman F. D., Sandlund J. T., Pui C. H., Jeha S., Relling M. V. and Campbell P. K. (20140918). Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase. : Cancer chemotherapy and pharmacology.

MLA

Fernandez C A, Stewart E, Panetta J C, Wilkinson M R, Morrison A R, Finkelman F D, Sandlund J T, Pui C H, Jeha S, Relling M V and Campbell P K. Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase. : Cancer chemotherapy and pharmacology. 20140918.